Stimulants · ICD-10 F15.10

Methamphetamine Addiction in Louisville, KY

Name: Golden Grove Recovery
Address: 4418 Malcolm Ave, Louisville, KY, 40211, US
Telephone: (502) 610-4829
Price range: $$

Methamphetamine is a powerful stimulant that causes extreme dopamine release, strong psychological dependence, and significant medical and psychiatric harm.

Call (502) 610-4829 Verify Insurance

Overview

What methamphetamine addiction looks like.

Methamphetamine is a powerful stimulant that causes extreme dopamine release, strong psychological dependence, and significant medical and psychiatric harm. Kentucky has seen a sustained rise in meth-related hospitalizations and deaths — often complicated by co-use with opioids. There are no FDA-approved medications for meth addiction, which makes structured behavioral treatment and integrated mental health care the standard of care.

Also known as: meth, crystal meth, methamphetamine, ice.

Signs of use

What patients and families actually notice.

Rapid, dramatic weight loss
Dental decay ("meth mouth") and skin sores
Long waking periods (days) followed by extended sleep
Hyperactivity, rapid speech, hyperfocus on repetitive tasks
Paranoia, hallucinations, or psychosis
Severe mood swings and aggression
Deteriorating work, school, and family functioning
Using despite escalating medical, legal, or psychiatric consequences

Withdrawal timeline

What withdrawal tends to look like.

Every person's experience varies. The windows below describe typical clinical patterns — your care team adjusts the plan based on how you respond.

24–72 hours

— Crash: severe fatigue
— hypersomnia
— depression
— increased appetite

Days 3–10

— Intense dysphoria
— anhedonia
— strong cravings
— cognitive dulling
— irritability

Weeks 2–4

— Mood and sleep gradually improve
— cravings remain strong
— anxiety and depression may persist

Weeks 4–12+

— Post-acute withdrawal: mood lability
— attention problems
— anhedonia — extended relapse-risk window

Treatment approach

How we treat methamphetamine addiction.

Medically monitored stabilization

While meth withdrawal is not typically life-threatening, medical monitoring supports safety in patients with psychiatric symptoms, cardiac complications, or polysubstance use.

Learn more →

Residential treatment

Structured residential care gives patients protected time during the acute post-use psychiatric window and supports early skill-building.

Learn more →

Contingency management

Contingency management (CM) is the most effective behavioral treatment for stimulant use disorder and is supported by strong evidence.

Learn more →

Cognitive Behavioral Therapy

CBT addresses relapse triggers, thought patterns, and skill deficits that drive return-to-use.

Learn more →

Integrated mental health care

Meth use frequently produces or worsens anxiety, depression, and psychotic symptoms; integrated psychiatric and SUD care is essential.

Learn more →

In Kentucky

The local picture.

Kentucky continues to see rising methamphetamine-related deaths, with meth increasingly involved in polysubstance overdoses alongside fentanyl. Louisville's demand for stimulant-focused treatment has grown meaningfully over the past five years.

Kentucky Medicaid coverage

Methamphetamine Addiction is typically covered.

Kentucky Medicaid plans typically cover residential, PHP, IOP, and outpatient SUD services for stimulant use disorder. There are no FDA-approved medications specifically for meth addiction, but behavioral treatment and integrated psychiatric care for co-occurring conditions are covered.

Coverage is determined by medical necessity using ASAM criteria. Our admissions team verifies your specific plan during your first call.

Frequently asked

Questions we hear most often.

Is meth withdrawal dangerous?

Meth withdrawal is usually not life-threatening in the way alcohol or benzodiazepine withdrawal can be, but it produces severe depression and suicidal ideation in some patients. Medical and psychiatric monitoring is strongly recommended.

Is there a medication for meth addiction?

No medication is FDA-approved for stimulant use disorder. Evidence-based behavioral treatments — particularly contingency management and CBT — are the standard of care, along with treatment of any co-occurring psychiatric conditions.

Does Kentucky Medicaid cover meth rehab?

Yes. All Kentucky Medicaid plans cover residential, PHP, IOP, and outpatient services for stimulant use disorder based on medical-necessity determinations.

Other substances we treat

The full treatment scope.

Adderall Misuse and Stimulant Use Disorder

Alcohol Use Disorder

Benzodiazepine Addiction

Cocaine Addiction

Fentanyl Addiction

Heroin Addiction

Opioid Use Disorder

Take the next step

Discuss methamphetamine addiction with our admissions team.

24/7 admissions. Insurance verification in minutes. Most KY Medicaid plans accepted. No judgment, no pressure, no obligation.

Call (502) 610-4829 Verify Insurance